Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trustworthy and explainable AI for drug discovery.

Expert opinion on drug discovery·2026
Same author

Response to letter regarding "AI‑based analysis of label‑free live‑cell imaging of T‑cell-mediated tumor killing".

SLAS discovery : advancing life sciences R & D·2026
Same author

AI-based analysis of label-free live cell imaging of T-cell mediated tumor killing assay enables competitive and robust hit calling.

SLAS discovery : advancing life sciences R & D·2026
Same author

PCIM: Learning pixel attributions via pixel-wise channel isolation mixing in high content imaging.

SLAS discovery : advancing life sciences R & D·2025
Same author

Advancing large-molecule discovery with a unified digital platform for data analysis and workflow management.

mAbs·2025
Same author

A robust CETSA data analysis automation workflow for routine screening.

SLAS discovery : advancing life sciences R & D·2024
Same journal

Revolutionizing Transcriptomics: From Single-Cell Insights to RNA-based Interventions.

SLAS technology·2026
Same journal

Smartphone-based colorimetric glucose biosensor using peroxidase-like activity of bimetallic catalyst supported onto graphitic carbon nitride nanosheets.

SLAS technology·2026
Same journal

XVCF: Exquisite visualization of VCF data from genomic experiments.

SLAS technology·2026
Same journal

EasyPip: An equipment-agnostic software application to transform automated liquid handlers into efficient walk-up tools for routine plate-based pipetting.

SLAS technology·2026
Same journal

Identification of ubiquitination-related biomarkers in osteoarthritis: Combining transcriptome and Mendelian randomization analysis.

SLAS technology·2026
Same journal

Miniaturization of a Lumit p-ERK immunoassay for cell-based high-throughput screening of a chemogenetic small-molecule library.

SLAS technology·2026
See all related articles

Related Experiment Video

Updated: Oct 6, 2025

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.7K

Benchmarking feature selection methods for compressing image information in high-content screening.

Daniel Siegismund1, Matthias Fassler1, Stephan Heyse1

  • 1Genedata AG, Margarethenstrasse 38, 4053 Basel, Switzerland.

SLAS Technology
|January 21, 2022
PubMed
Summary
This summary is machine-generated.

This study compares 12 feature selection methods for High Content Screening (HCS) in biopharmaceutical drug discovery. It offers guidance on selecting optimal features and methods for improved drug development, whether using supervised or unsupervised techniques.

Keywords:
Automated machine learningBig dataDrug discoveryFeature selectionHigh-content screening

More Related Videos

A High-content Imaging Workflow to Study Grb2 Signaling Complexes by Expression Cloning
10:52

A High-content Imaging Workflow to Study Grb2 Signaling Complexes by Expression Cloning

Published on: October 30, 2012

10.8K
Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging
08:40

Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging

Published on: April 8, 2016

13.0K

Related Experiment Videos

Last Updated: Oct 6, 2025

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.7K
A High-content Imaging Workflow to Study Grb2 Signaling Complexes by Expression Cloning
10:52

A High-content Imaging Workflow to Study Grb2 Signaling Complexes by Expression Cloning

Published on: October 30, 2012

10.8K
Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging
08:40

Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging

Published on: April 8, 2016

13.0K

Area of Science:

  • Biopharmaceutical drug discovery
  • High Content Screening (HCS)
  • Automated microscopy imaging assays

Background:

  • High Content Screening (HCS) generates high-dimensional data from automated microscopy.
  • Extracting maximal information from HCS requires extensive feature extraction and complex analysis.
  • Automated feature selection is crucial for reducing data complexity and enhancing interpretability in drug development.

Purpose of the Study:

  • To compare the performance of 12 state-of-the-art feature selection methods (supervised and unsupervised).
  • To evaluate the generalizability and importance of selected features using automated machine learning (AutoML).
  • To provide practical guidance for experimental design and method selection in HCS-based drug discovery.

Main Methods:

  • Systematic testing of 12 feature selection algorithms on two relevant HCS datasets.
  • Utilizing automated machine learning (AutoML) for unbiased evaluation of selected features.
  • Assessing feature selection performance using standard plate, assay, and compound statistics.

Main Results:

  • Identified effective feature selection strategies for HCS data analysis.
  • Demonstrated the utility of both supervised and unsupervised methods based on data characteristics.
  • Provided insights into optimal feature set sizing for meaningful interpretation.

Conclusions:

  • Feature selection significantly impacts the interpretability and utility of HCS data in drug discovery.
  • The choice between supervised and unsupervised methods depends on the availability of experimental controls.
  • Results offer practical recommendations for optimizing HCS experimental design and data analysis pipelines.